This premier meeting will bring together oncology professionals from across the Asia-Pacific region and beyond to explore the latest scientific and clinical advances in cancer care.

The congress will offer a high-quality scientific programme addressing the most prevalent cancer types in Asia, with a strong focus on state-of-the-art multidisciplinary care. 

Participants will gain insights into key breakthroughs in molecular oncology, including advances in prognostication and risk-adapted treatment strategies.

Through interactive and multidisciplinary sessions, the programme will highlight the integration of emerging diagnostics, biomarker-driven approaches, targeted therapies, and artificial intelligence into clinical practice.